Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Patients' Right to Health Protection and Quality and Safety of Blood(Products)

Patients' Right to Health Protection and Quality and Safety of Blood(Products) European Journal of Health Law 11 : 155-168, 2005. 153 © 2005 Koninklijke Brill N.V. Printed in the Netherlands Patients’ Right to Health Protection and Quality and Safety of Blood(Products) VEELKE DERCKX AND HENRIETTE ROSCAM ABBING * 1. Introduction In December 2003, the Health Secretary of the United Kingdom informed the parliament of the death of a person who was probably victim of the variant Creutz- feldt-Jakob disease (vCJD). This because of transfusion of blood in 1996 from a donor who had been incubating vCJD. As a precautionary measure, the United Kingdom decided to exclude from blood-donation all those who had received a blood transfusion since January 1980. Following this event, the Dutch organisation in charge of the blood supply, Sanquin, asked the Minister of Health, Welfare and Sport to apply the same measure in the Netherlands. This request did not receive a positive answer because the measure was considered inefficient, the risks for the health of blood recipients were considered extremely low as sofar no cases of vCJD had been detected in the Netherlands yet, and the chance that cases would occur was considered very small. After a second case of infection with vCJD through blood in http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Health Law Brill

Patients' Right to Health Protection and Quality and Safety of Blood(Products)

Loading next page...
 
/lp/brill/patients-right-to-health-protection-and-quality-and-safety-of-blood-sl2CVdjZb7

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Brill
Copyright
© 2005 Koninklijke Brill NV, Leiden, The Netherlands
ISSN
0929-0273
eISSN
1571-8093
DOI
10.1163/1571809054640668
Publisher site
See Article on Publisher Site

Abstract

European Journal of Health Law 11 : 155-168, 2005. 153 © 2005 Koninklijke Brill N.V. Printed in the Netherlands Patients’ Right to Health Protection and Quality and Safety of Blood(Products) VEELKE DERCKX AND HENRIETTE ROSCAM ABBING * 1. Introduction In December 2003, the Health Secretary of the United Kingdom informed the parliament of the death of a person who was probably victim of the variant Creutz- feldt-Jakob disease (vCJD). This because of transfusion of blood in 1996 from a donor who had been incubating vCJD. As a precautionary measure, the United Kingdom decided to exclude from blood-donation all those who had received a blood transfusion since January 1980. Following this event, the Dutch organisation in charge of the blood supply, Sanquin, asked the Minister of Health, Welfare and Sport to apply the same measure in the Netherlands. This request did not receive a positive answer because the measure was considered inefficient, the risks for the health of blood recipients were considered extremely low as sofar no cases of vCJD had been detected in the Netherlands yet, and the chance that cases would occur was considered very small. After a second case of infection with vCJD through blood in

Journal

European Journal of Health LawBrill

Published: Jan 1, 2005

There are no references for this article.